BHIC (BioScience Health Innovations) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


BHIC BioScience Health Innovations Inc BHIC
45 GF Score
Price $4.35
GF Value $164.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is BioScience Health Innovations Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

BioScience Health Innovations's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BHIC vs PETS, SHFH, SCNX: Margin of Safety % (DCF FCF Based) Comparison

For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioScience Health Innovations Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where BioScience Health Innovations's Margin of Safety % (DCF FCF Based) falls into.


BHIC
45GF Score
BioScience Health Innovations Inc BHIC
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioScience Health Innovations (BHIC) Overvalued in 2026?

Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued. The current stock price of $4.35 is trading 97.4% below its estimated GF Value™ of $164.84. GuruFocus considers BioScience Health Innovations to be Possible Value Trap.

Key valuation signals for BHIC:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $164.84 vs. price of $4.35 (97.4% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioScience Health Innovations Business Description

Address 14857 South Concord Park Drive, Bluffdale, UT, USA, 84065
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
45GF Score

Get the complete analysis for BHIC

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.35
Price
$164.84
GF Value